Avastin News
Most Popular Avastin Story
MAbs are hottest segment of biotech industry
Looking for the hottest segment of the biotech industry? Then take a look at monoclonal antibodies (mAbs). A new Datamonitor report projects 14 percent annual growth in the market for the antibody... Read more...
Latest Headlines
- May 19, 2009
- April 22, 2009
- July 2, 2008
- June 3, 2008
- May 16, 2008
- May 16, 2008
- April 21, 2008
- March 4, 2008
- February 27, 2008
- February 22, 2008
- February 19, 2008
- January 15, 2008
- November 20, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
